Connor, Clark & Lunn Investment Management Ltd. Jazz Pharmaceuticals PLC Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 18,633 shares of JAZZ stock, worth $2.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

18,633

Previous 23,735 21.5%

Holding current value

$2.27 Million

Previous $2.53 Million 18.04%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$100.57 - $116.37 $513,108 - $593,719	-5,102 Reduced 21.5%	18,633 $2.08 Million
Q2 2024 Aug 09, 2024	SELL	$103.94 - $118.98 $11.2 Million - $12.8 Million	-107,281 Reduced 81.88%	23,735 $2.53 Million
Q1 2024 May 09, 2024	SELL	$115.19 - $132.77 $6.06 Million - $6.99 Million	-52,647 Reduced 28.67%	131,016 $15.8 Million
Q4 2023 Feb 09, 2024	BUY	$114.26 - $136.0 $828,042 - $985,592	7,247 Added 4.11%	183,663 $22.6 Million
Q3 2023 Nov 13, 2023	SELL	$122.0 - $145.31 $7.62 Million - $9.08 Million	-62,477 Reduced 26.15%	176,416 $22.8 Million
Q2 2023 Aug 10, 2023	BUY	$122.5 - $147.16 $1.57 Million - $1.89 Million	12,851 Added 5.69%	238,893 $29.6 Million
Q1 2023 May 09, 2023	BUY	$133.98 - $160.47 $1.75 Million - $2.09 Million	13,028 Added 6.12%	226,042 $33.1 Million
Q4 2022 Feb 10, 2023	BUY	$129.72 - $159.85 $11.6 Million - $14.3 Million	89,671 Added 72.7%	213,014 $33.9 Million
Q3 2022 Nov 10, 2022	BUY	$126.59 - $161.18 $4.54 Million - $5.78 Million	35,849 Added 40.97%	123,343 $16.4 Million
Q2 2022 Aug 05, 2022	BUY	$141.59 - $168.66 $3.02 Million - $3.59 Million	21,307 Added 32.19%	87,494 $13.7 Million
Q1 2022 May 12, 2022	SELL	$129.64 - $160.7 $1.33 Million - $1.64 Million	-10,232 Reduced 13.39%	66,187 $10.3 Million
Q4 2021 Feb 10, 2022	BUY	$119.87 - $145.67 $4.26 Million - $5.18 Million	35,552 Added 86.99%	76,419 $9.74 Million
Q3 2021 Nov 12, 2021	BUY	$128.64 - $184.79 $5.26 Million - $7.55 Million	40,867 New	40,867 $5.32 Million
Q3 2019 Nov 13, 2019	SELL	$125.18 - $143.24 $441,259 - $504,921	-3,525 Closed	0 $0
Q2 2019 Aug 07, 2019	SELL	$125.55 - $144.48 $301,320 - $346,752	-2,400 Reduced 40.51%	3,525 $503,000
Q1 2019 May 08, 2019	BUY	$121.81 - $142.95 $721,724 - $846,978	5,925 New	5,925 $847,000
Q4 2018 Feb 12, 2019	SELL	$115.94 - $166.74 $182,605 - $262,615	-1,575 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$161.01 - $180.57 $253,590 - $284,397	1,575 New	1,575 $265,000

Others Institutions Holding JAZZ

# of Institutions

513

Shares Held

57.7M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.63B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Jazz Pharmaceuticals PLC Transaction History